GlassScriptPhysician profile
Kyle G Flowers
NPI 1063710580
$2,672.02
in general payments reported to CMS, 2019-2025
26 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $119 · 2021: $62.92 · 2022: $586 · 2023: $312 · 2024: $780 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $648.18 | 2022-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $503.69 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sirtex Medical INC | $183.36 | 2019-2020 | |
| Ge Healthcare | $181.82 | 2024 | |
| Angiodynamics, INC. | $176.29 | 2023 | Auryon Laser System 100-120 Vac |
| Shockwave Medical, INC | $145.18 | 2025 | |
| Medtronic, INC. | $139.58 | 2022 | |
| Stryker Corporation | $134.99 | 2019 | |
| Bard Peripheral Vascular, INC. | $133.79 | 2019 | |
| Becton, Dickinson and Company | $86.38 | 2024 | Lutonix Drug Coated Balloon, Venovo, Covera |
| Boston Scientific Corporation | $48.68 | 2024 | Obsidio |
| Astrazeneca Pharmaceuticals LP | $42.56 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $29.48 | 2024 | Artis Icono Floor |
| Ipsen Biopharmaceuticals, INC | $26.63 | 2020 | |
| Medtronic USA, INC. | $19.66 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $18.61 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.31 | 2019 | |
| Blueprint Medicines Corporation | $17.57 | 2021 | |
| Amgen INC. | $16.69 | 2021 | |
| Daiichi Sankyo INC. | $16.29 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.54 | 2020 | |
| Karyopharm Therapeutics INC. | $14.84 | 2021 | |
| Seagen INC. | $14.25 | 2019 | |
| Celgene Corporation | $13.58 | 2019 | |
| Pfizer INC. | $13.56 | 2020 | |
| Janssen Biotech, INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Flowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.